docetaxel anhydrous has been researched along with Stevens-Johnson Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, J; Chaudhary, S; Ghazala, S; Jarrett, B | 1 |
| Kabashima, R; Nakamura, M; Sawada, Y; Sugita, K; Tokura, Y | 1 |
| Engelmann, U; Heidenreich, A; Kohlmorgen, S; Ohlmann, CH; Sahi, D | 1 |
1 trial(s) available for docetaxel anhydrous and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
[Lethal course after chemotherapy with docetaxel. Acute liver failure with accompanying erythema multiforme major].
Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Chemical and Drug Induced Liver Injury; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Eruptions; Fatal Outcome; Humans; Liver Failure; Liver Function Tests; Male; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Stevens-Johnson Syndrome; Taxoids | 2007 |
2 other study(ies) available for docetaxel anhydrous and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
Case of Steven-Johnson Syndrome in a male with breast cancer secondary to docetaxel/cyclophosphamide therapy.
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Breast Neoplasms, Male; Cyclophosphamide; Docetaxel; Exanthema; Fatal Outcome; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Mucositis; Plasmapheresis; Pneumonia, Pneumocystis; Respiratory Insufficiency; Stevens-Johnson Syndrome; Taxoids | 2016 |
Docetaxel-induced Stevens-Johnson syndrome with regenerating epidermis composed of atypical keratinocytes.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Epidermis; Female; Humans; Keratinocytes; Middle Aged; Stevens-Johnson Syndrome; Taxoids | 2009 |